Close

Rating History for NovaBay Pharmaceuticals (nby) by Ascendiant Capital

More Stocks Rated by Ascendiant Capital | Latest Ratings for nby
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/14/2023 Edward Woo Maintain Buy
(N/A)		 9.50
(10.00)		  
 		   Details